SCHEMBL316588

SCHEMBL316588

C/[C]=N\O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL454128 1.00
SCHEMBL667117 1.00
SCHEMBL1498193 0.65
SCHEMBL1666538 0.65
SCHEMBL177760 0.59
SCHEMBL8170052 0.59
SCHEMBL3752303 0.59
SCHEMBL2439268 0.56
SCHEMBL21994500 0.56
SCHEMBL4396694 0.56

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 796 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024053650-A1 COMPOUND HAVING INHIBITORY ACTIVITY AGAINST DIACYLGLYCEROL KINASE α AND/OR ζ, AND PHARMACEUTICAL USE THEREOF 小野薬品工業株式会社 2024-03-14 WO claimed
US-20200261420-A1 ENHANCEMENT OF CANCER TREATMENT EFFICIENCY VIA THE SPHINGOSINE-1-PHOSPHATE PATHWAY AC BIOSCIENCE (CH) 2020-08-20 US claimed
EP-3668506-A1 ENHANCEMENT OF CANCER TREATMENT EFFICIENCY VIA THE SPHINGOSINE-1-PHOSPHATE PATHWAY AC BioScience (CH) 2020-06-24 EP claimed
WO-2019034768-A1 ENHANCEMENT OF CANCER TREATMENT EFFICIENCY VIA THE SPHINGOSINE-1-PHOSPHATE PATHWAY AC BIOSCIENCE (CH) 2019-02-21 WO claimed
US-20180153830-A1 SELECTIVE INHIBITORS OF UNDIFFERENTIATED CELLS YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) 2018-06-07 US claimed
US-9790202-B2 Anthranilamide derivatives as pesticides BAYER INTELLECTUAL PROPERTY GMBH (DE) 2017-10-17 US claimed
US-20170027890-A1 SELECTIVE INHIBITORS OF UNDIFFERENTIATED CELLS YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) 2017-02-02 US claimed
EP-2590964-B1 ANTHRANILIC ACID DIAMIDE DERIVATIVES AS PESTICIDES BAYER IP GMBH (DE) 2015-10-07 EP claimed
US-20150148359-A1 SELECTIVE INHIBITORS OF UNDIFFERENTIATED CELLS YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) 2015-05-28 US claimed
EP-2226322-B1 IMIDAZOLE CARBONYL COMPOUND DAIICHI SANKYO CO LTD (JP) 2015-01-21 EP claimed
US-4617307-A Substituted imidazo[1,5-A]pyridine derivatives as aromatase inhibitors CIBA-GEIGY CORPORATION (US) 1986-10-14 US claimed
EP-0118070-B1 SUBSTITUTED 1,3-DIAZOLYL-2-PROPANOLS, PROCESS FOR THEIR PREPARATION AND THEIR USE AS ANTIMYCOTIC COMPOUNDS BAYER AG (DE) 1986-10-08 EP claimed
EP-0043292-B1 PROSTAGLANDINS NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1986-01-15 EP claimed
EP-0105166-A1 Substituted tert. butanol derivatives, method for their preparation and antimycotic agents containing them BAYER AG (DE) 1984-04-11 EP claimed
US-4442115-A ANTI-ASTHMA MAY & BAKER LIMITED (GB) 1984-04-10 US claimed
EP-0085028-A2 N-Phenylsulfonyl-N'-pyrimidinyl and triazinyl ureas CIBA-GEIGY AG (CH) 1983-08-03 EP claimed
EP-0018674-A1 Benzodioxincarboxylic acid derivatives, their preparation and their inclusion in lipogenesis inhibiting compositions SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1980-11-12 EP claimed
US-4205076-A Lipogenesis inhibition by certain esters of substituted benzodioxincarboxylic acids SHELL OIL COMPANY (US) 1980-05-27 US claimed
US-4205079-A LIPORENESIS INHIBITORS SHELL OIL COMPANY (US) 1980-05-27 US claimed
US-4202818-A Lipogenesis inhibition by certain esters of substituted benzodioxincarboxylic acids SHELL OIL COMPANY (US) 1980-05-13 US claimed